Get Live Data
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. SLI.L Share Price
  4. SLI.L Share Regulatory News
  5. Update research from QuotedData

Pin to quick picksSLI.L Regulatory News (SLI)

SLI.L Information
  • There is currently no data for SLI

Update research from QuotedData

30 Apr 2021 16:35

RNS Number : 2952X
Standard Life Invs Property Inc Tst
30 April 2021
 

QuotedData's Real Estate Quarterly Review - first quarter 2021 - Update research from QuotedData

30th April 2021

 

Lockdown cloud begins to lift

 

The success of the vaccine rollout in the UK and the implementation of a roadmap out of lockdown saw the share prices of listed property companies - most of which had been decimated during the last year - make somewhat of a recovery.

 

Full research:

https://quoteddata.com/research/quoteddatas-real-estate-quarterly-review-q1-2021/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: This report has been prepared by Marten & Co and is for information purposes only. It is not intended to encourage the readerto deal in any of the securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors.

 

QUOTEDDATA123a Kings Road | London SW3 4PLTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUROVRAOUSOAR
12345678910
Date   Source Headline
5th Jul 20162:32 pmPRNUpdate
14th Jun 20167:00 amPRNPublication of Supplementary Prospectus
3rd Jun 20164:01 pmPRNDirectorate Change
2nd Jun 20161:26 pmPRNResults of Annual General Meeting
27th May 20169:17 amPRNDirector Declaration
19th May 20167:00 amPRNSLIPIT Sale
11th May 20167:00 amPRNDividend
11th May 20167:00 amPRNNet Asset Value
6th May 20164:20 pmPRNNotice of Annual General Meeting
28th Apr 20167:00 amPRNDebt Refinancing
19th Apr 20167:00 amPRNAnnual Report and Accounts
11th Mar 20167:00 amPRNDirector Changes
11th Mar 20167:00 amPRNDirector Changes
8th Mar 20167:00 amPRNDividend
10th Feb 20167:00 amPRNUnaudited Net Asset Value
20th Jan 20164:05 pmPRNDisclosure of Home Member State
31st Dec 20159:48 amPRNDTR 5.6.1. Disclosure - Total Voting Rights
30th Dec 201511:07 amPRNDirector PDMR Shareholding
24th Dec 201511:10 amPRNDirector Dealing
23rd Dec 20151:18 pmPRNCompletion of portfolio acquisition
22nd Dec 20154:49 pmPRNHolding(s) in Company
18th Dec 20152:49 pmPRNSLIPIT Sale
18th Dec 20152:49 pmPRNResults of Capital Raising & Portfolio Acquisition
16th Dec 201511:12 amPRNDividend Announcement
15th Dec 201512:51 pmPRNPublication of Supplementary Prospectus
11th Dec 201512:06 pmPRNResults of General Meeting
10th Dec 20152:43 pmPRNExtension to the Initial Placing and Offer
9th Dec 20157:00 amPRNExtension of the offer
18th Nov 20157:00 amPRNPublication of Prospectus and Circular
13th Nov 20159:00 amPRNFundraising and Acquisition of Property Portfolio
9th Nov 20157:00 amPRNSLIPIT Sale
3rd Nov 20159:06 amPRNDividend Declaration
22nd Oct 201511:38 amRNSEdison update-Standard Life Property Income Trust
20th Oct 20157:00 amPRNUnaudited Net Asset Value
28th Sep 20157:00 amPRNProposed portfolio acquisition and capital raising
22nd Sep 20157:00 amPRNSignificant Asset Management for SLIPIT
27th Aug 20151:06 pmPRNHalf-yearly Report
12th Aug 20159:29 amPRNSLIPIT rebalances portfolio
30th Jul 20157:00 amPRNUnaudited Net Asset Value
27th Jul 201512:05 pmPRNDividend Declaration
27th Jul 20157:00 amPRNPurchase
23rd Jul 20155:07 pmPRNPurchase
22nd Jul 201512:47 pmPRNDirector Declaration
26th Jun 20159:54 amPRNHolding(s) in Company
26th Jun 20159:44 amPRNREIT Status and PID
24th Jun 201510:49 amPRNSLIPIT Purchase
18th Jun 201511:58 amPRNResult of Placing
15th Jun 20159:24 amPRNSLIPIT Sale
12th Jun 20157:00 amPRNIntention to Issue Equity
27th May 20151:26 pmPRNResult of Annual General Meeting
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
BOIL
BOIL.L
LSE
0.00%
TFIF
Twentyfour Inc
LSE
0.00%
GBPG
Goldman Sachs Access UK Gilts 1-10 Years UCITS ETF Class GBP (Dist)
LSE
0.01%
PGH
Personal Group
LSE
0.00%
SYN
Synergia Energy
LSE
0.00%
Trending
IMM
Immupharma
LSE
-2.26%
ALRT
Defence Holdings
LSE
19.05%
SBTX
Skinbiotherap.
LSE
0.00%
PREM
Premier African Minerals
LSE
9.52%